Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Scott Hansen

Surgery San Francisco, CA Medical Doctor

NPI 1548224694 CMS profile 205322

350 Parnassus Ave Ste 509, San Francisco, CA 94143

Open in the dashboard

General payments

$185,980

299 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Scott Hansen of San Francisco, CA is reported in the CMS Open Payments database as having received $185,980 across 299 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,627 19
2024 General $25,347 46
2023 General $31,501 39
2022 General $61,884 77
2021 General $4,378 10
2020 General $9,297 21
2019 General $50,945 87

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Hansen
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Scott Hansen were reported at $2,627. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Scott Hansen Surgery median Middle half National median
2019 $50,945 $253 $82–$1,521 $163
2020 $9,297 $131 $40–$706 $114
2021 $4,378 $168 $50–$904 $132
2022 $61,884 $224 $76–$1,218 $149
2023 $31,501 $253 $82–$1,255 $160
2024 $25,347 $279 $90–$1,381 $164
2025 $2,627 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Integra LifeSciences Corporation $92,166 105 payments
  2. Smith+Nephew, Inc. $87,467 147 payments
  3. Musculoskeletal Transplant Foundation Inc. $2,031 13 payments
  4. Kerecis Limited $1,398 8 payments
  5. TissueTech, Inc. $676 6 payments
  6. Medical Microinstruments, Inc. $595 4 payments
  7. AxoGen $553 5 payments
  8. Endo Pharmaceuticals Inc. $200 1 payment
  9. Alafair Biosciences,Inc. $197 1 payment
  10. Skeletal Dynamics Inc $151 1 payment
  11. Other $547 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $81,465 25 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $51,900 25 payments
  3. Travel and Lodging $42,214 122 payments
  4. Food and Beverage $10,279 125 payments
  5. Education $122 2 payments
Products named General payments · program years 2019–2025
  1. Integra Recon-Skin And Wound $46,713 57 payments
  2. Integra Recon-Skin And Wound $46,402 54 payments
  3. ADVANCED WOUND CARE $34,448 20 payments
  4. VERSAJET II $32,044 43 payments
  5. Versajet $28,006 50 payments
  6. PICO Single Use Negative Pressure Wound Therapy $16,592 33 payments
  7. PRIMATRIX $9,814 44 payments
  8. NEURAGEN $7,249 5 payments
  9. INTEGRA DERMAL REGENERATION TEMPLATE $5,566 40 payments
  10. Integra Recon-Skin And Wound $5,126 32 payments
  11. Other $29,160 140 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$17,538

Medicare's payments for the services billed

Medicare patients

78

Average age 68

Services billed

158

44 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 59%
Arthritis 46%
Diabetes 32%
Chronic kidney disease 32%
Ischemic heart disease 27%
Depression 22%
Atrial fibrillation 17%
Osteoporosis 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

299 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record